Basic Information
| LncRNA/CircRNA Name | CTC-276P9.1 |
| Synonyms | C5orf66-AS1, CTC-276P9.1, Epist |
| Region | GRCh38_5:135038831-135040047 |
| Ensemble | ENSG00000249082 |
| Refseq | NR_105049 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | bladder cancer |
| ICD-0-3 | C67 |
| Methods | Microarray, qPCR, RNAi etc. |
| Sample | bladder cancer tissues |
| Expression Pattern | down-regulated |
| Function Description | Four lncRNAs were selected for further confirmation of microarray results using qPCR. These lncRNAs were among the most downregulated or upregulated lncRNAs. Data analysis showed that KRT19P3 was upregulated and TNXA, CTA-134P22.2 and CTC-276P9.1 were downregulated in bladder cancer samples compared with matched normal tissues.these deregulated lncRNAs play a key or partial role in the development and/or progression of bladder cancer. |
| Pubmed ID | 24944692 |
| Year | 2014 |
| Title | Long noncoding RNA expression signatures of bladder cancer revealed by microarray. |
External Links
| Links for CTC-276P9.1 | GenBank HGNC NONCODE |
| Links for bladder cancer | OMIM COSMIC |